AbbVie’s Skyrizi Gets Approval In US For Ulcerative Colitis Stock Market Stocks to buy Stocks to sell admin June 19, 2024 0 92 1 minute read (RTTNews) – AbbVie Inc. (ABBV) Wednesday said the Food and Drug Administration (FDA) has approved Skyrizi for the treatment of ulcerative colitis.